IQ4I Research & Consultancy Published a New Report on “Diagnostic Imaging Global Market– Forecast To 2022”

Boston, MA, March 18, 2016 --(PR.com)-- IQ4I’s Report contains 162 market data tables and 49 figures spread through 413 pages and an exhaustive TOC on “Diagnostic Imaging Global Market [Products (Computed Tomography Scanners, Nuclear Imaging(NI) Equipments, Magnetic Resonance Imaging Systems, Ultrasound Scanners, X-ray Devices and Others), Technology (Computed Tomography, Nuclear Imaging(NI), Magnetic Resonance Imaging, Ultrasound, X-ray and Others), Applications (Cardiovascular diseases, Oncology, Abdominal related problems, Neurological disorders, Orthopedic related problems, Gynecology and others), End-Users (Hospitals, Diagnostic laboratories and Research laboratories), Region (North America, Europe, APAC and RoW)].

This report analyzes the diagnostic imaging global market in terms of market revenue ($ million) for all segments and it enables diagnostic imaging manufacturers, product distributors and wholesalers, diagnostic imaging laboratories, hospitals, OEM (Original Equipment Manufacturers)/Contract manufacturers, Group Purchasing Organizations (GPOs), various research and consulting firms and other associated stake holders to identify and analyze market expansion opportunities, upcoming technologies, technological developments, competition in diagnostic imaging global market.

An imaging technique performed by professionals to visualize the internal structures of the body for diagnosis purposes is usually referred as diagnostic imaging. There have been revolutionary advancements from the past few years in diagnostic imaging right from point of care monitoring to digital scanning, making it convenient and user friendly especially to elder people. Diagnostic imaging is being identified as one of the matured markets among the healthcare sector. Advances in diagnostic imaging technology have redefined how physicians diagnose and treat some of the most life threatening diseases such as cancer and heart disease and they have nearly eliminated the need for exploratory surgery. Imaging techniques would be therefore enabling us to diagnose, treat and cure patients without causing any harmful side effects. According to IQ4I estimates, the diagnostic imaging global market is expected to reach $38,315 million by 2022.

There are many factors involved in driving the growth of the diagnostic imaging market such as emerging applications in diagnostic procedures, high prevalence of the diseases, ongoing research activities all over the world and most important thing, awareness in people about the use of early disease diagnosis. On the other hand, the high cost of the diagnostic imaging systems, risk of the radiation exposure, shortage of helium for MRI systems, poor healthcare insurance coverage particularly for the diagnostic procedures are restricting the market growth. There will be an upward trend for refurbished systems due to lower costs as well as acquiring advanced systems.

Toshiba, the fourth largest player in the diagnostic imaging market planned to sell at least 51% of its healthcare business in order to bolster balance sheet and invest in its energy and flash memory business. Toshiba’s medical equipment business is one of the profits making unit for the company. The prime contenders in this race Canon, Fujifilm, Konica Minolta and Permira are raising the prospect of a bidding war. The probability of sale to an overseas company is ruled-out considering regulatory issues, Toshiba has considered Canon’s proposal to be most attractive, but still the finalized deal yet to be announced. Canon’s camera business segments is in declined trend, due to emergence of smart phones and is planning to strategically strengthen its medical device business and compete with the giant players in diagnostic imaging market such as GE, Philips and Siemens.

The Globally Diagnostic imaging technologies market is segmented into product outlook, technology outlook, applications and end-users. Product outlook is further segmented into Computed Tomography (CT) scanners, Nuclear Imaging (NI) equipment, Magnetic Resonance Imaging (MRI) systems, Ultrasound scanners and X-ray devices and others. Technology outlook is also alienated again into Computed Tomography (CT), Nuclear Imaging (NI), Magnetic Resonance Imaging (MRI), Ultrasound, x-ray and others. Application outlook is classified into Cardiovascular Diseases (CVD’s), Cancer, Neurological disorders, abdominal related problems, Orthopedic related problems, gynecology related problems and others. Depending on the end-users, the market is segmented into hospitals, private diagnostic laboratories and research laboratories.

North America holds the largest share in the global diagnostic imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the fastest CAGR in the coming five years. The Asian and Latin American countries represent the fastest growing markets due to increasing government support for research and rising industry and academic partnerships for research activities. But still the factors like economic slowdown, pricing pressures may compel the companies to focus on Asian markets.

Some of the key players in the global diagnostic imaging market include Analogic Corporation (U.S.), Carestream Health, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Hitachi Medical Corporation (Japan), Hologic, Inc. (U.S.), Samsung Medison (South Korea), Shimadzu Corporation (Japan) and Toshiba Medical Systems Corporation (Japan).